Akorn gets FDA's warning letter related to New Jersey manufacturing plant
Akorn Inc said on Tuesday the U.S. Food and Drug Administration has raised certain issues related to the inspection of its Somerset, New Jersey manufacturing facility in July and August of 2018.
from Reuters: Health News https://reut.rs/2Ncui4A
http://bit.ly/2zwRqiM